The Cellular Stress and Cutaneous Manifestations in Renal Cell Carcinomas—A Narrative Review
-
Published:2024-06-21
Issue:13
Volume:13
Page:3640
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Ene Corina Daniela12, Nicolae Ilinca3, Tampa Mircea45ORCID, Georgescu Simona Roxana45, Ene Cosmin67, Matei Clara4, Leulescu Iulia Maria Teodora5, Mitran Cristina Iulia8, Mitran Madalina Irina8, Capusa Cristina12
Affiliation:
1. Department of Nephrology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania 2. Department of Nephrology, ‘Carol Davila’ Nephrology Hospital, 010731 Bucharest, Romania 3. Research Department, ‘Victor Babes’ Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania 4. Department of Dermatology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania 5. Department of Dermatology, ‘Victor Babes’ Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania 6. Department of Urology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania 7. Department of Urology, “Saint John” Clinical Emergency Hospital, 13 Vitan-Barzesti, 042122 Bucharest, Romania 8. Department of Microbiology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania
Abstract
The carcinomas originating from the renal cortex are the most aggressive renal malignancies, with a high tendency for metastasis. Understanding the incidence of cutaneous manifestations caused by renal carcinomas is a challenge. In the first part, this article summarizes a series of factors that promote oncogenesis, invasiveness, and the ability of renal cell carcinoma (RCC) to develop secondary cutaneous manifestations. It is postulated that the cellular stress response is one of the leading causes of developing dermatological events induced by cancers located at distant sites. Furthermore, the paper provides an overview of cutaneous complications associated with renal cancer, categorized as malignant manifestations (metastases, synchronous or metachronous cutaneous malignancies associated with renal cancer), non-malignant indirect cutaneous manifestations associated with renal cancer, and treatment consequences. The data presented in this article suggest that recognizing certain cutaneous disorders could assist the physician in the early identification of renal neoplasms and could lead to a better prognosis.
Funder
University of Medicine and Pharmacy Carol Davila
Reference134 articles.
1. Garfield, K., and LaGrange, C.A. (2023). Renal Cell Cancer. StatPearls, StatPearls Publishing. 2. Ene, C.D., Tampa, M., Georgescu, S.R., Matei, C., Leulescu, I.M.T., Dogaru, C.I., Penescu, M.N., and Nicolae, I. (2023). Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma. Cancers, 15. 3. Ene, C.D., Penescu, M.N., Georgescu, S.R., Tampa, M., and Nicolae, I. (2020). Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma. Metabolites, 11. 4. Schiavoni, V., Campagna, R., Pozzi, V., Cecati, M., Milanese, G., Sartini, D., Salvolini, E., Galosi, A.B., and Emanuelli, M. (2023). Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies. Cancers, 15. 5. Kaldas, M.V., and Eid, M.P. (2024, May 02). Dermatologic Manifestations of Paraneoplastic Syndromes. Available online: https://emedicine.medscape.com/article/1095113-overview.
|
|